Canadian Association for the Study of the Liver

Today, we join the Global Liver Institute in marking the 7th annual #GlobalFattyLiverDay. We’re committed to spotlight the importance of early detection and treatment of #fattyliver disease. With 1 in 3 adults affected globally, it’s time to start prevention now. We encourage everyone to get screened or schedule a check-up, especially if you’re at risk. Embrace an active lifestyle to boost liver health and stay informed about fatty #liverdisease and its treatments. Your Health Matters. #ActNowScreenToday! Together, we can reverse the tide of this disease. Join us in raising awareness and taking action for #LiverHealth. Canadian Association for the Study of the Liver (CASL) is a non-profit organization that seeks to eliminate liver disease through research, education and advocacy. Our members are experts on liver disease in Canada: hepatologists, gastroenterologists, pediatricians, surgeons, radiologists, researchers, nurses, trainees, community advocates, and patients and family partners. For more information, visit our website at www.hepatology.ca.

In March 2024, the American Association for the Study of Liver Diseases (AASLD) announced the selection of sixty-two #hepatology leaders as Fellows and one allied #healthleader focused on hepatology as an Associate Fellow. Congratulations to #CASLMembers Carla Coffin, Giada Sebastiani, and Hin Hin Ko! 👏 Full list available at https://lnkd.in/gErYzcwK

New Abstract by #CASLmember Gerald Minuk, CASL Gold Medal Awardee, and Nabiha Faisal, speaking in the upcoming Best of EASL, CASL Webinar Series.   Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated with steatotic liver disease. https://lnkd.in/dMA_6Wh4 #JournalAlert #CanLivJ #MemberSpotlight #hepatology #medicine #liver #healthcare #liverdisease

CASL's President Carla Coffin joined colleagues from the Canadian Liver Foundation, Action Hepatitis Canada, Canadian Hepatitis B Network, Candian Network on Hepatitis C, and others, for #CanHepDay24 to advocate for greater progress towards Viral Hepatitis Elimination in Canada. You can watch the speech on the link below. https://lnkd.in/da86fjg6

Today for #CanHepDay24 we are in Ottawa with Action Hepatitis Canada, CanHepC, CanHepB, and the Canadian Liver Foundation to hold governments accountable to their commitment to eliminate viral #Hepatitis as a public health threat by 2030! Here is what we are asking: ✅ Targets to measure progress toward hepatitis elimination ✅ Evidence-based hep B & C screening guidelines ✅ Point-of-care testing approval ✅ Universal birth-dose hep B vaccination ✅ Updated hep B & C estimates Thank you to our many members and allies who are helping amplify our call. #HepCantWait Read more: http://bit.ly/3WBO3on

For #CanHepDay24 we ask our government to add targets to measure progress in eliminating viral #hepatitis to the 2025-2030 STBBI Action Plan Help us amplify our call for our government #HepCantWait 🔗https://bit.ly/3WBO3on

Thank you to #CASL members who are helping amplify our call for the federal government, as well as each province and territory, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. #HepCantWait #CanHepDay24 https://bit.ly/3WBO3on

For #CanHepDay24 we ask our government to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. Help us amplify our call for the federal and provincial governments. #HepCantWait 🔗https://bit.ly/3WBO3on #hepatitis #by2030

Hepatitis C is curable and hepatitis B is treatable.  We are asking our government to engage manufacturers of point-of-care testing technologies to bring these tests to Canada. #HepCantWait #CanHepDay24 https://bit.ly/3WBO3on #hepatitis #by2030

Le jeudi 9 mai 2024, l'Association canadienne pour l'étude du foie se joindra à Action Hépatite Canada, CanHepC, CanHepB et la Fondation canadienne du foie pour souligner la 3e Journée canadienne annuelle d'élimination de l'hépatite virale à Ottawa. CINQ DEMANDES AU GOUVERNEMENT FÉDÉRAL En 2016, le Canada s'est engagé à l'échelle internationale à éliminer l'hépatite virale en tant que menace pour la santé publique d'ici 2030. Même si une grande partie de ce travail incombe aux provinces et aux territoires, le gouvernement fédéral peut prendre cinq mesures clés dès maintenant. 1. Planification : Ajouter des cibles pour mesurer les progrès dans l’élimination des hépatites virales au Plan d’action 2025-2030 pour les ITSS. 2. Dépistage : Mettre à jour les lignes directrices en matière de dépistage de l'hépatite C pour qu'elles soient fondées sur des données probantes, élaborer des lignes directrices fondées sur des données probantes pour le dépistage de l'hépatite B et commencer à offrir des tests de dépistage des ITSS gratuits et volontaires ainsi qu'un lien vers les soins pour tous les immigrants et nouveaux arrivants. 3. Lien entre tests et traitement : Engager les fabricants de tests diagnostiques et confirmation à introduire ces tests au Canada. 4. Prévention : Mettre à jour les lignes directrices du CCNI afin de recommander la vaccination universelle contre l'hépatite B à la naissance. 5. Données : Financer et accroître les efforts visant à recueillir des estimations actualisées de la prévalence de l'hépatite B et C et des cascades de soins spécifiques à la population pour toutes les provinces et territoires canadiens. Canadian Association for the Study of the Liver #CanHepDay24 #HepCantWait